PHE says it is investigating more than a thousand cases of the new strain
News
NICE u-turn on Novartis’ migraine drug Aimovig
New analyses submitted by Novartis has helped to secure a NICE recommendation for NHS funding
Novartis’ cholesterol med Leqvio wins EU approval
Drug approved to help reduce cholesterol levels
EU nod for AZ’ COPD maintenance therapy
The triple combination therapy Trixeo Aerosphere cut the rate of moderate or severe exacerbations compared with dual-combination therapies in clinical trials
Bumper December meeting sees CHMP recommend 15 new medicines
Ehertu, Inrebic and Retsevmo among positive recommendations
Albireo submits rare liver disease med odevixibat to FDA and EMA
If approved, drug will become first treatment for PFIC patients in the US and EU
CRUK researchers develop new early-stage rectal cancer treatment
New treatment could prevent debilitating side effects of standard major surgery
Alunbrig scores NICE backing for ALK-positive lung cancer
ALK inhibitor recommended in the first-line non-small cell lung cancer setting
Sanofi, GSK face COVID-19 vaccine trial delay
Potential availability of vaccine now delayed to the end of 2021
Crescendo Biologics expands Takeda collaboration
Follows previous agreements signed in November 2018 and July 2019
FDA set to review GSK’s Nucala for nasal polyps
Submission is based on data from the pivotal SYNAPSE study
Enhertu scores ‘impressive’ new data in HER2+ breast cancer
Updated data from DESTINY-Breast01 trial continues to demonstrate efficacy
MHRA issues allergy warning for Pfizer/BioNTech COVID-19 jab
Updated guidance warns people with a history of allergic reactions not to receive the shot
Kite’s CAR T therapy Yescarta shows potential in new indication
ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma
Pfizer’s pneumococcal disease vaccine scores FDA priority review
Vaccine candidate previously scored fast-track and breakthrough therapy designations
